Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of Cancer Resistance to Immunotherapy. | Front Oncol | 2020 | 32850400 | PubTator, text mining | PubMed |
| MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment. | Cells | 2020 | 32823933 | PubTator, text mining | PubMed |
| Catalytic Mechanism of Aromatic Nitration by Cytochrome P450 TxtE: Involvement of a Ferric-Peroxynitrite Intermediate. | J Am Chem Soc | 2020 | 32811149 | PubTator, text mining | PubMed |
| Stem Cell-Based Therapeutic Approaches to Restore Sensorineural Hearing Loss in Mammals. | Neural Plast | 2020 | 32802037 | PubTator, text mining | PubMed |
| Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma. | Oncol Lett | 2020 | 32782601 | PubTator, text mining | PubMed |
| The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence. | Biomolecules | 2020 | 32781654 | PubTator, text mining | PubMed |
| Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond? | Precis Cancer Med | 2020 | 32776005 | PubTator, text mining | PubMed |
| Liver regeneration and alcoholic liver disease. | Ann Transl Med | 2020 | 32775368 | PubTator, text mining | PubMed |
| Analysis of patents targeting antimetastatic effect using herbal materials. | Integr Med Res | 2020 | 32775196 | PubTator, text mining | PubMed |
| Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. | Breast Cancer Res Treat | 2020 | 32767201 | PubTator, text mining | PubMed |
| Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature. | Front Med (Lausanne) | 2020 | 32760731 | PubTator, text mining | PubMed |
| The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. | Cancers (Basel) | 2020 | 32759723 | PubTator, text mining | PubMed |
| Comparative genomic analysis of eutherian fibroblast growth factor genes. | BMC Genomics | 2020 | 32758140 | PubTator, text mining | PubMed |
| Unraveling the Mechanism of the IrIII -Catalyzed Regiospecific Synthesis of α-Chlorocarbonyl Compounds from Allylic Alcohols. | Chemistry | 2020 | 32757212 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System. | Int J Mol Sci | 2020 | 32751460 | PubTator, text mining | PubMed |
| From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. | Cancers (Basel) | 2020 | 32751137 | PubTator, text mining | PubMed |
| Role of YES1 amplification in EGFR mutation-positive non-small cell lung cancer: Primary resistance to afatinib in a patient. | Thorac Cancer | 2020 | 32744377 | PubTator, text mining | PubMed |
| TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection. | EBioMedicine | 2020 | 32739866 | PubTator, text mining | PubMed |
| Anlotinib as a molecular targeted therapy for tumors. | Oncol Lett | 2020 | 32724339 | PubTator, text mining | PubMed |
| Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. | Clin Cancer Res | 2020 | 32723837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=41